Benchmark Maintains Buy on Agilon Health, Raises Price Target to $13

agilon health inc

agilon health inc

AGL

0.00

Benchmark analyst Bill Sutherland maintains Agilon Health (NYSE: AGL) with a Buy and raises the price target from $1.5 to $13.